Understanding the Roles of FAK in Cancer

Focal adhesion kinase (FAK) is a protein tyrosine kinase that regulates cellular adhesion, motility, proliferation and survival in various types of cells. Interestingly, FAK is activated and/or overexpressed in advanced cancers, and promotes cancer progression and metastasis. For this reason, FAK became a potential therapeutic target in cancer, and small molecule FAK inhibitors have been developed and are being tested in clinical phase trials. These inhibitors have demonstrated to be effective by inducing tumor cell apoptosis in addition to reducing metastasis and angiogenesis. Furthermore, several genetic FAK mouse models have made advancements in understanding the specific role of FAK both in tumors and in the tumor environment. In this review, we discuss FAK inhibitors as well as genetic mouse models to provide mechanistic insights into FAK signaling and its potential in cancer therapy.

[1]  Joseph Geradts,et al.  High focal adhesion kinase expression in invasive breast carcinomas is associated with an aggressive phenotype , 2005, Modern Pathology.

[2]  J. Parsons,et al.  Focal adhesion kinase: the first ten years , 2003, Journal of Cell Science.

[3]  Andrea I. McClatchey,et al.  Merlin Deficiency Predicts FAK Inhibitor Sensitivity: A Synthetic Lethal Relationship , 2014, Science Translational Medicine.

[4]  Meifang Fang,et al.  [Expression and clinical significance of focal adhesion kinase in oral squamous cell carcinoma]. , 2006, Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition.

[5]  Osamu Ohmori,et al.  A novel low‐molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth , 2007, Molecular carcinogenesis.

[6]  M. Eck,et al.  The FERM domain: organizing the structure and function of FAK , 2010, Nature Reviews Molecular Cell Biology.

[7]  A. Herrero,et al.  Overexpression of Focal Adhesion Kinase in Head and Neck Squamous Cell Carcinoma Is Independent of fak Gene Copy Number , 2006, Clinical Cancer Research.

[8]  Daniel A. Fletcher,et al.  Cell mechanics and the cytoskeleton , 2010, Nature.

[9]  Paolo P. Provenzano,et al.  Tumorigenesis and Neoplastic Progression Mammary Epithelial-Specific Disruption of Focal Adhesion Kinase Retards Tumor Formation and Metastasis in a Transgenic Mouse Model of Human Breast Cancer , 2008 .

[10]  Susan J Fisher,et al.  Nuclear FAK promotes cell proliferation and survival through FERM-enhanced p53 degradation. , 2008, Molecular cell.

[11]  R. Matusik,et al.  Prostate cancer in a transgenic mouse. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Zhe Chen,et al.  Activated RhoA Binds to the Pleckstrin Homology (PH) Domain of PDZ-RhoGEF, a Potential Site for Autoregulation*♦ , 2010, The Journal of Biological Chemistry.

[13]  T. Hunter,et al.  Pyk2 and Src‐family protein‐tyrosine kinases compensate for the loss of FAK in fibronectin‐stimulated signaling events but Pyk2 does not fully function to enhance FAK− cell migration , 1998, The EMBO journal.

[14]  V. Golubovskaya,et al.  Focal Adhesion Kinase Versus p53: Apoptosis or Survival? , 2008, Science Signaling.

[15]  M. Tang,et al.  Suppression of Ultraviolet Irradiation-induced Apoptosis by Overexpression of Focal Adhesion Kinase in Madin-Darby Canine Kidney Cells* , 1999, The Journal of Biological Chemistry.

[16]  A. Magis,et al.  A novel small molecule inhibitor of FAK decreases growth of human pancreatic cancer , 2009, Cell cycle.

[17]  D. Schlaepfer,et al.  Integrin-regulated FAK-Src signaling in normal and cancer cells. , 2006, Current opinion in cell biology.

[18]  Anil K Sood,et al.  Biological significance of focal adhesion kinase in ovarian cancer: role in migration and invasion. , 2004, The American journal of pathology.

[19]  A. Orr,et al.  Regulation of endothelial cell function BY FAK and PYK2. , 2004, Frontiers in bioscience : a journal and virtual library.

[20]  Youngsin Jung,et al.  Band 4.1 proteins regulate integrin-dependent cell spreading. , 2012, Biochemical and biophysical research communications.

[21]  M. H. Chui.  Insights into cancer metastasis from a clinicopathologic perspective: Epithelial‐Mesenchymal Transition is not a necessary step , 2013, International journal of cancer.

[22]  G. Mcmahon,et al.  PND-1186 FAK inhibitor selectively promotes tumor cell apoptosis in three-dimensional environments , 2010, Cancer biology & therapy.

[23]  C. Steindler,et al.  TGFbeta-induced EMT requires focal adhesion kinase (FAK) signaling. , 2008, Experimental cell research.

[24]  S. Hanks,et al.  Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases , 1995, Molecular and cellular biology.

[25]  Li Zhang,et al.  The direct effect of Focal Adhesion Kinase (FAK), dominant-negative FAK, FAK-CD and FAK siRNA on gene expression and human MCF-7 breast cancer cell tumorigenesis , 2009, BMC Cancer.

[26]  L. Mei,et al.  Regulation of heterochromatin remodelling and myogenin expression during muscle differentiation by FAK interaction with MBD2 , 2009, The EMBO journal.

[27]  Christopher Autry,et al.  Cellular Characterization of a Novel Focal Adhesion Kinase Inhibitor* , 2007, Journal of Biological Chemistry.

[28]  W. Cance,et al.  Attenuation of the expression of the focal adhesion kinase induces apoptosis in tumor cells. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[29]  Shanrong Liu,et al.  Pluripotency transcription factors and cancer stem cells: small genes make a big difference , 2013, Chinese journal of cancer.

[30]  M. Wicha,et al.  Mammary epithelial-specific ablation of the focal adhesion kinase suppresses mammary tumorigenesis by affecting mammary cancer stem/progenitor cells. , 2009, Cancer research.

[31]  D. Schlaepfer,et al.  v-Src SH3-enhanced Interaction with Focal Adhesion Kinase at β1 Integrin-containing Invadopodia Promotes Cell Invasion* , 2002, The Journal of Biological Chemistry.

[32]  Jean-Antoine Girault,et al.  FAK dimerization controls its kinase‐dependent functions at focal adhesions , 2014, The EMBO journal.

[33]  J. Parsons,et al.  Inhibition of Focal Adhesion Kinase by PF-562,271 Inhibits the Growth and Metastasis of Pancreatic Cancer Concomitant with Altering the Tumor Microenvironment , 2011, Molecular Cancer Therapeutics.

[34]  E. Chen,et al.  Cancer stem cells, tumor dormancy, and metastasis , 2012, Front. Endocrin..

[35]  S. Hanks,et al.  Induced Focal Adhesion Kinase (FAK) Expression in FAK-Null Cells Enhances Cell Spreading and Migration Requiring Both Auto- and Activation Loop Phosphorylation Sites and Inhibits Adhesion-Dependent Tyrosine Phosphorylation of Pyk2 , 1999, Molecular and Cellular Biology.

[36]  A. Sood,et al.  Enhancing anti-angiogenic therapy by blocking focal adhesion kinase , 2011 .

[37]  J. Gribben,et al.  Endothelial-cell FAK targeting sensitizes tumours to DNA-damaging therapy , 2014, Nature.

[38]  J. Baselga,et al.  TGF-β Receptor Inhibitors Target the CD44(high)/Id1(high) Glioma-Initiating Cell Population in Human Glioblastoma. , 2010, Cancer cell.

[39]  S. Morrison,et al.  Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[40]  V. Golubovskaya,et al.  A small molecule focal adhesion kinase (FAK) inhibitor, targeting Y397 site: 1-(2-hydroxyethyl)-3, 5, 7-triaza-1-azoniatricyclo [3.3.1.1(3,7)]decane; bromide effectively inhibits FAK autophosphorylation activity and decreases cancer cell viability, clonogenicity and tumor growth in vivo. , 2012, Carcinogenesis.

[41]  Cynthia Hawkins,et al.  Identification of a cancer stem cell in human brain tumors. , 2003, Cancer research.

[42]  J. Guan,et al.  Conditional deletion of FAK in mice endothelium disrupts lung vascular barrier function due to destabilization of RhoA and Rac1 activities. , 2013, American journal of physiology. Lung cellular and molecular physiology.

[43]  D. Brenner,et al.  The Focal Adhesion Kinase Suppresses Transformation-associated, Anchorage-independent Apoptosis in Human Breast Cancer Cells , 2000, The Journal of Biological Chemistry.

[44]  D. Simeone,et al.  Identification of human pancreatic cancer stem cells. , 2009, Methods in molecular biology.

[45]  C. Damsky,et al.  FAK integrates growth-factor and integrin signals to promote cell migration , 2000, Nature Cell Biology.

[46]  C. Lipinski,et al.  Targeting Pyk2 for therapeutic intervention , 2010, Expert opinion on therapeutic targets.

[47]  E. Peles,et al.  Protein tyrosine kinase PYK2 involved in Ca2+-induced regulation of ion channel and MAP kinase functions , 1995, Nature.

[48]  S. Lim.  Nuclear FAK: a new mode of gene regulation from cellular adhesions , 2013, Molecules and cells.

[49]  R. Cardiff,et al.  Mammary epithelial-specific disruption of the focal adhesion kinase blocks mammary tumor progression , 2007, Proceedings of the National Academy of Sciences.

[50]  Clive R. Bagshaw,et al.  Phosphatidylinositol Phosphate Kinase Type 1γ and β1-Integrin Cytoplasmic Domain Bind to the Same Region in the Talin FERM Domain* , 2003, Journal of Biological Chemistry.

[51]  Ting Liu,et al.  [Expression of KAI1, MRP-1, and FAK proteins in lung cancer detected by high-density tissue microarray]. , 2005, Ai zheng = Aizheng = Chinese journal of cancer.

[52]  E. Dejana,et al.  Inhibition of endothelial FAK activity prevents tumor metastasis by enhancing barrier function , 2014, The Journal of cell biology.

[53]  V. Golubovskaya,et al.  Nanog Increases Focal Adhesion Kinase (FAK) Promoter Activity and Expression and Directly Binds to FAK Protein to Be Phosphorylated* , 2012, The Journal of Biological Chemistry.

[54]  D. Ito,et al.  Clinical Significance of Focal Adhesion Kinase in Resectable Pancreatic Cancer , 2006, World Journal of Surgery.

[55]  J. Guan,et al.  Regulation of Focal Adhesion Kinase by Its Amino-Terminal Domain through an Autoinhibitory Interaction , 2003, Molecular and Cellular Biology.

[56]  J. Girault,et al.  Autophosphorylation-independent and -dependent Functions of Focal Adhesion Kinase during Development* , 2009, The Journal of Biological Chemistry.

[57]  S. Weiss,et al.  Snail1 controls epithelial–mesenchymal lineage commitment in focal adhesion kinase–null embryonic cells , 2011, The Journal of cell biology.

[58]  S. Lim,et al.  Knock-in Mutation Reveals an Essential Role for Focal Adhesion Kinase Activity in Blood Vessel Morphogenesis and Cell Motility-Polarity but Not Cell Proliferation* , 2010, The Journal of Biological Chemistry.

[59]  V. Golubovskaya,et al.  Direct Interaction of the N-terminal Domain of Focal Adhesion Kinase with the N-terminal Transactivation Domain of p53* , 2005, Journal of Biological Chemistry.

[60]  S. Theocharis,et al.  Focal adhesion kinase expression is not a prognostic predictor in colon adenocarcinoma patients. , 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[61]  Q. Ding,et al.  Focal adhesion kinase is expressed in the angiogenic blood vessels of malignant astrocytic tumors in vivo and promotes capillary tube formation of brain microvascular endothelial cells. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[62]  S. Grant,et al.  Specific deletion of focal adhesion kinase suppresses tumor formation and blocks malignant progression. , 2004, Genes & development.

[63]  J. Guan,et al.  Stimulation of cell migration by overexpression of focal adhesion kinase and its association with Src and Fyn. , 1996, Journal of cell science.

[64]  D. Schlaepfer,et al.  FAK in cancer: mechanistic findings and clinical applications , 2014, Nature Reviews Cancer.

[65]  Shin-Young Park,et al.  RAFTK/Pyk2-mediated cellular signalling. , 2000, Cellular signalling.

[66]  Ann Y Park,et al.  Role of kinase-independent and -dependent functions of FAK in endothelial cell survival and barrier function during embryonic development , 2010, The Journal of cell biology.

[67]  R. Braren,et al.  Endothelial FAK is essential for vascular network stability, cell survival, and lamellipodial formation , 2006, The Journal of cell biology.

[68]  W. Cance,et al.  The COOH-terminal domain of the focal adhesion kinase induces loss of adhesion and cell death in human tumor cells. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[69]  T. Lechertier,et al.  Focal adhesion kinase and tumour angiogenesis , 2012, The Journal of pathology.

[70]  W. Kim,et al.  Focal adhesion kinase (FAK) gene amplification and its clinical implications in gastric cancer. , 2010, Human pathology.

[71]  J. Guan,et al.  Focal adhesion kinase: from in vitro studies to functional analyses in vivo. , 2011, Current protein & peptide science.

[72]  S. Lim,et al.  FERM control of FAK function: Implications for cancer therapy , 2008, Cell cycle.

[73]  R. Franco,et al.  Variations of Proline-Rich Kinase Pyk2 Expression Correlate with Prostate Cancer Progression , 2001, Laboratory Investigation.

[74]  Xinming Cai,et al.  Structural Basis for the Autoinhibition of Focal Adhesion Kinase , 2007, Cell.

[75]  M. Wicha,et al.  Distinct FAK activities determine progenitor and mammary stem cell characteristics. , 2013, Cancer research.

[76]  D. Schlaepfer,et al.  The Focal Adhesion Kinase‐‐A Regulator of Cell Migration and Invasion , 2002, IUBMB life.

[77]  Xu-Qian Fang,et al.  Somatic mutational analysis of FAK in breast cancer: a novel gain-of-function mutation due to deletion of exon 33. , 2014, Biochemical and biophysical research communications.

[78]  R. Weinberg,et al.  Integrin β1-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs , 2009, Proceedings of the National Academy of Sciences.

[79]  S. Lim,et al.  Nuclear-localized focal adhesion kinase regulates inflammatory VCAM-1 expression , 2012, The Journal of cell biology.

[80]  G. McLean,et al.  Src-induced de-regulation of E-cadherin in colon cancer cells requires integrin signalling , 2002, Nature Cell Biology.

[81]  B. Zhou,et al.  The Role of Snail in EMT and Tumorigenesis. , 2013, Current cancer drug targets.

[82]  J. Guan,et al.  VEGF-induced vascular permeability is mediated by FAK. , 2012, Developmental cell.

[83]  Tony Hunter,et al.  Multiple Grb2-Mediated Integrin-Stimulated Signaling Pathways to ERK2/Mitogen-Activated Protein Kinase: Summation of Both c-Src- and Focal Adhesion Kinase-Initiated Tyrosine Phosphorylation Events , 1998, Molecular and Cellular Biology.

[84]  P. Massion,et al.  Expression of focal adhesion kinase in small‐cell lung carcinoma , 2012, Cancer.

[85]  Matthew D. Wessel,et al.  Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562,271. , 2008, Cancer research.

[86]  H. Kuwano,et al.  FAK overexpression is correlated with tumour invasiveness and lymph node metastasis in oesophageal squamous cell carcinoma , 2003, British Journal of Cancer.

[87]  W. Yung,et al.  Inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor kinase suppresses glioma proliferation in vitro and in vivo , 2007, Molecular Cancer Therapeutics.

[88]  W. Cance,et al.  Expression of focal adhesion kinase gene and invasive cancer , 1993, The Lancet.

[89]  E. Ruoslahti,et al.  Control of adhesion-dependent cell survival by focal adhesion kinase , 1996, The Journal of cell biology.

[90]  A. Sood,et al.  Abstract LB-230: Enhancing anti-angiogenic therapy by blocking focal adhesion kinase , 2011 .

[91]  G. Mcmahon,et al.  Oral delivery of PND-1186 FAK inhibitor decreases tumor growth and spontaneous breast to lung metastasis in pre-clinical models , 2010, Cancer biology & therapy.

[92]  A. Magis,et al.  A small molecule inhibitor, 1,2,4,5-benzenetetraamine tetrahydrochloride, targeting the y397 site of focal adhesion kinase decreases tumor growth. , 2008, Journal of medicinal chemistry.

[93]  S. Sprang,et al.  Modulation of a GEF switch: Autoinhibition of the intrinsic guanine nucleotide exchange activity of p115‐RhoGEF , 2011, Protein science : a publication of the Protein Society.

[94]  M. Eck,et al.  Crystal Structure of the FERM Domain of Focal Adhesion Kinase* , 2006, Journal of Biological Chemistry.

[95]  Jenny G. Parvani,et al.  TGF-β stimulates Pyk2 expression as part of an epithelial-mesenchymal transition program required for metastatic outgrowth of breast cancer , 2013, Oncogene.

[96]  S. Aizawa,et al.  Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice , 1995, Nature.

[97]  C. Steindler,et al.  TGFβ-induced EMT requires focal adhesion kinase (FAK) signaling , 2008 .

[98]  V. Brunton,et al.  The role of focal adhesion kinase catalytic activity on the proliferation and migration of squamous cell carcinoma cells , 2012, International journal of cancer.

[99]  K. Baggerly,et al.  Focal adhesion kinase , 2014, Cancer biology & therapy.

[100]  P. Marker.  Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells , 2007 .

[101]  Jihe Zhao,et al.  Signal transduction by focal adhesion kinase in cancer , 2009, Cancer and Metastasis Reviews.

[102]  M. Iacocca,et al.  Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[103]  Wenjun Guo,et al.  Slug and Sox 9 Cooperatively Determine the Mammary Stem Cell State Citation , 2022 .

[104]  Liz Y. Han,et al.  Therapeutic efficacy of a novel focal adhesion kinase inhibitor TAE226 in ovarian carcinoma. , 2007, Cancer research.

[105]  H. Frierson,et al.  Differential requirement for focal adhesion kinase signaling in cancer progression in the transgenic adenocarcinoma of mouse prostate model , 2009, Molecular Cancer Therapeutics.

[106]  J. Girault,et al.  Organization and post-transcriptional processing of focal adhesion kinase gene , 2006, BMC Genomics.

[107]  J. Parsons,et al.  Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src , 1994, Molecular and cellular biology.

[108]  D. Camidge,et al.  Safety, pharmacokinetic, and pharmacodynamic phase I dose-escalation trial of PF-00562271, an inhibitor of focal adhesion kinase, in advanced solid tumors. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[109]  M. Clarke,et al.  Identification of pancreatic cancer stem cells. , 2007, Cancer research.

[110]  A. Liaqat,et al.  Perforated duodenal ulcer associated with anterior abdominal abscess: A case report. , 2012, The Australasian medical journal.

[111]  B. van de Water,et al.  Mammary gland-specific ablation of focal adhesion kinase reduces the incidence of p53-mediated mammary tumour formation , 2014, British Journal of Cancer.

[112]  M. Parsons,et al.  Endothelial FAK is required for tumour angiogenesis , 2010, EMBO molecular medicine.

[113]  E. Parkinson,et al.  Increased dosage and amplification of the focal adhesion kinase gene in human cancer cells , 1999, Oncogene.

[114]  V. Golubovskaya,et al.  Focal Adhesion Kinase Expression in Human Neuroblastoma: Immunohistochemical and Real-time PCR Analyses , 2008, Clinical Cancer Research.

[115]  J. Dick,et al.  Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell , 1997, Nature Medicine.

[116]  J. Guan,et al.  Mammary Epithelial-specific Deletion of the Focal Adhesion Kinase Gene Leads to Severe Lobulo-Alveolar Hypoplasia and Secretory Immaturity of the Murine Mammary Gland* , 2007, Journal of Biological Chemistry.

[117]  Tsuey-Ming Chen,et al.  Pathobiology of autochthonous prostate cancer in a pre‐clinical transgenic mouse model , 2003, The Prostate.

[118]  J. Ihle.  The Janus protein tyrosine kinase family and its role in cytokine signaling. , 1995, Advances in immunology.

[119]  R. Flavell,et al.  Conditional knockout of focal adhesion kinase in endothelial cells reveals its role in angiogenesis and vascular development in late embryogenesis , 2005, The Journal of cell biology.

[120]  I. Zachary,et al.  Focal adhesion kinase. , 1997, The international journal of biochemistry & cell biology.

[121]  D. Noh,et al.  Clinical significance of high focal adhesion kinase gene copy number and overexpression in invasive breast cancer , 2011, Breast Cancer Research and Treatment.

[122]  J. Guan,et al.  FAK-mediated src phosphorylation of endophilin A2 inhibits endocytosis of MT1-MMP and promotes ECM degradation. , 2005, Developmental cell.

[123]  A. Ishisaki,et al.  Transforming growth factor-β1 induces epithelial-mesenchymal transition and integrin α3β1-mediated cell migration of HSC-4 human squamous cell carcinoma cells through Slug. , 2013, Journal of biochemistry.

[124]  D. A. Hanson,et al.  Focal adhesion kinase: in command and control of cell motility , 2005, Nature Reviews Molecular Cell Biology.